1Zlotnik A,Yoshie O.Chemokines: a new classification system and their role in immunity[].Immunity.2000
2Marra F.Chemokines in liver inflammation and fibrosis[].Front Biosci.2002
3Kusano F,Tanaka Y,Marumo F,Sato C.Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C[].Lab Invest.2000
4Hellier S,Frodsham AJ,Hennig BJ,Klenerman P,Knapp S,Ramaley P,Satsangi J,Wright M,Zhang L,Thomas HC,Thursz M,Hill AV.Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection[].Hepatology.2003
5Goulding C,McManus R,Murphy A,MacDonald G,Barrett S,Crowe J,Hegarty J,McKiernan S,Kelleher D.The CCR5- delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source[].Gut.2005
6Vicari AP,Caux C.Chemokines in cancer[].Cytokine Growth Factor Rev.2002
7Manes S,Mira E,Colomer R,Montero S,Real LM,Gomez- Mouton C,Jimenez-Baranda S,Garzon A,Lacalle RA,Harshman K,Ruiz A,Martinez-A C.CCR5 expression influences the progression of human breast cancer in a p53- dependent manner[].J Exp Med.2003
9Winkler C,Modi W,Smith MW,Nelson GW,Wu X,Carrington M,Dean M,Honjo T,Tashiro K,Yabe D,Buchbinder S,Vittinghoff E,Goedert JJ,O’Brien TR,Jacobson LP,Detels R,Donfield S,Willoughby A,Gomperts E,Vlahov D,Phair J,O’Brien SJ.Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)[].Science.1998
10Nahon P,Sutton A,Pessayre D,Rufat P,Degoul F,Ganne- Carrie N,Ziol M,Charnaux N,N’kontchou G,Trinchet JC,Gattegno L,Beaugrand M.Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death[].Clin Gastroenterol Hepatol.2005
2CHIU H Y,SUN K H,CHEN S Y, et al. Autocrine CCL2 pro-motes cell migration and invasion via PKC activation and tyrosinephosphorylation of paxillin in bladder cancer cells[ J]. Cytokine,2012,59(2) : 423 -432.
3FANG W B, JOKAR I,ZOU A, et al. CCL2/CCR2 chemokinesignaling coordinates survival and motility of breast cancer cellsthrough Smad3 protein and p42/44 mitogen - activated protein ki-nase (MAPK) - dependent mechanisms[ J]. J Biol Chem, 2012,287(43): 36593 -36608.
4ZHANG J, PATEL L, PIENTA K J. Targeting chemokine (C - Cmotif) ligand 2 ( CCL2 ) as an example of translation of cancer mo-lecular biology to the clinic [ J ] . Prog Mol Biol Transl Sci, 2010 ,95: 31 -53.
5ZHANG J,LU Y,PIENTA K J. Multiple roles of chemokine ( C -C motif) ligand 2 in promoting prostate cancer growth [ J ]. J NatlCancer Inst, 2010,102(8) : 522 -528.
6HINGE J, STRASSBURG S,NEUMANN K, et al. Towards in si-tu tissue repair .. human mesenchymal stem cells express chemokinereceptors CXCR1,CXCR2 and CCR2,and migrate upon stimula-tion with CXCL8 but not CC12 [ J ]. J Cell Biochem, 2007,101(1); 135 -146.
7VANDE B I,ASOSINGH K, VANDERKERKEN K, et al. Che-mokine receptor CCR2 is expressed by human multiple myelomacells and mediates migration to bone marrow stromal cell - pro-duced monocyte chemotactic proteins MCP - 1,- 2 and - 3 [ J ].Br J Cancer, 2003, 88(6) : 855 -862.
8LU Y, CAI Z, XIAO G,et al. CCR2 expression correlates withprostate cancer progression[J]. J Cell Biochem, 2007, 101(3):676 一685.
9ROCA H,VARSOS Z S, MIZUTANI K, et al. CCL2, survivinand autophagy : new links with implications in human cancer[ J].Autophagy, 2008, 4(7): 969-971.
10TSAI W H, SHIH C H, LIN C C, et al. Monocyte chemotacticprotein -1 in the migration of differentiated leukaemic cells towardalveolar epithelial cells[ J]. Eur Respir J,2008,31(5) : 957 -962.
